Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Perosphere, Inc.

http://www.perosphere.com

Latest From Perosphere, Inc.

Deal Watch: AbbVie Exits Inherited CRISPR-Cas9 Team-Up With Editas

Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.

Deals Business Strategies

UK Wellness Marketing Round-Up, May: Unbeelievable Health, NattoPharma, Wren, Vitabiotics And More

This month’s round-up of UK wellness marketing news features new mental health supplements from Unbeelievable Health, a new study supporting NattoPharma’s MenaQ7 vitamin K2 supplement, an award for Wren Laboratories' international activities, a probiotic Wellkid supplement from Vitabiotics, and five more wellness launches in brief.

Wellness Dietary Supplements

Which? Hunt – Industry Blasts Investigation Claiming That Supplements Sold In UK ‘Don’t Contain What They Say’

"The amount of the vitamins in the bottle didn’t match what’s listed on the packaging," said consumer group Which? after carrying out testing on a number of popular supplements. Branding the results "misleading", the manufacturers argue Which?'s methodology was "flawed" and its testing methods "not suitable."

Dietary Supplements Manufacturing

Vitabiotics’ Scholarly Ad Fails U.K. Test Despite Broadcast Group’s Tutoring

Reducing fatigue becomes a health claim when it is linked in advertising to the researcher who invented the product, the U.K.’s says. An implied health claim to treat or alleviate menopausal symptoms is not authorized by EU regulations, the standard the U.K. recognizes.

Consumer United Kingdom
See All

Company Information

  • Industry
  • Pharmaceuticals
UsernamePublicRestriction

Register